Vortex “As a clinician, I am excited about accessing the cancer biology of patient’s through CTCs. Vortex’s technology provides the best source of CTCs to aid in the diagnostic and treatment decisions we face every day.” – Dr. Jonathan Goldman, MD, Director of Clinical Trials in Thoracic Oncology, Associate Director of Drug Development at UCLA “Improving CTCs recovery along with high cellular purity while maintaining viability have tremendous value for translational research and clinical diagnostic applications. The VTX-1 holds the potential to revolutionize blood-based diagnostics.” - Pr. Massimo Cristofanilli, MD, FACP, Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine Wanda J. Cribbs, Lead Gartner Analyst Population Health & Analytics says: "Wanda's recent HRS press release really stands out. Delivering those results and having a client publicly share credit with their vendor is rare and says a lot. We at Gartner will have our eyes on Wanda in 2018"

Disclaimer – Important

DISCLAIMER – IMPORTANT

ACCESS TO THIS AREA OF THE WEBSITE MAY BE RESTRICTED UNDER SECURITIES LAWS OR REGULATIONS IN CERTAIN JURISDICTIONS. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS (INCLUDING THAT YOU ARE NOT RESIDENT IN SUCH A JURISDICTION), BEFORE YOU MAY OBTAIN ACCESS TO THE INFORMATION ON THIS AREA OF THE WEBSITE. THESE MATERIALS ARE NOT DIRECTED AT OR TO BE ACCESSED BY PERSONS RESIDENT IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION OR WOULD RESULT IN A REQUIREMENT OF NETSCIENTIFIC PLC TO COMPLY WITH ANY CONSENT OR OTHER FORMALITY WHICH NETSCIENTIFIC PLC REGARDS AS UNDULY ONEROUS

 

Strategic review, including formal sale process, by Netscientific plc (the “Company”)

 

You are attempting to enter the area of the website that is designated for the publication of documents and information in connection with the Company’s strategic review (the “Strategic Review”) including formal sale process (the “Formal Sale Process”).

Please read this notice carefully – it applies to all persons who view this webpage. Please note that the disclaimer set out below may be altered or updated. You should read it in full each time you visit the site.

This area of the website contains electronic versions of materials relating to the Strategic Review and the Formal Sale Process made available in compliance with the City Code on Takeovers and Offers. The materials you are seeking to access are made available by the Company in good faith and for information purposes only and are subject to the terms and conditions set out below. Any person seeking to access this part of the website represents and warrants to the Company that they are doing so for information purposes only.

To allow you to view information on this part of this website, you must read this notice and then click “I AGREE”. If you are unable to agree you must click “I DISAGREE”.

 

Viewing the materials you are seeking to access may be restricted under securities laws in certain jurisdictions. All persons resident outside of the United Kingdom who wish to view this part of the website must first satisfy themselves that they are not subject to any local requirements which prohibit or restrict them from doing so and should inform themselves about, and observe, any applicable legal or regulatory requirements applicable in their jurisdiction. Making the materials available on this website does not constitute an offer to sell or otherwise dispose of, or an invitation or solicitation of any offer to purchase or subscribe for, any securities. Further, it does not constitute a recommendation by the Company or any other party to sell or buy any securities.

If you are not permitted to view the materials on this part of the website, or viewing the materials would result in a breach of the above, or you are in any doubt as to whether you are permitted to view the materials, please exit this web page.

These materials are not directed at or intended to be accessible by persons resident in any jurisdiction if to do so would constitute a violation of the relevant laws or regulations of that jurisdiction.

Any offer resulting from the Formal Sale Process would be made solely by means of an offer or scheme document which would contain the full terms and conditions of such offer, including details of how it may be accepted. Any decision made in relation to such offer should be made solely and only on the basis of the information provided in any such document.

Basis of access

This area of the website contains information that has been prepared for the purposes of complying with English law and the City Code on Takeovers and Offers and the information disclosed may not be the same as that which would have been disclosed if this information had been prepared in accordance with the laws and regulations of any jurisdiction outside of England.

Access to electronic versions of these materials is being made available on this website by the Company in good faith and for information purposes only. Any person seeking access to this website represents and warrants to the Company that they are doing so for information purposes only. Making press announcements and other documents available in electronic format does not constitute an offer to sell or the solicitation of an offer to buy securities in the Company. Further, it does not constitute a recommendation by the Company or any other party to sell or buy securities in the Company.

Responsibility

In relation to any materials related to the Strategic Review and the Formal Sale Process that are accessible on this area of the website please note any statement of responsibility contained therein.

The documents included in this part of the website issued or published by the Company speak only at the specified date of the relevant document and the Company has, and accepts, no responsibility or duty to update or revise such documents.

Neither the directors of the Company, nor the Company nor any of their respective affiliated companies have reviewed, and no such person is or shall be responsible for or accepts any liability in respect of, any information contained on any other website which may be linked to or from this part of the website.

If you are in any doubt about the contents of this part of the website or the action you should take, you should seek your own financial advice from an independent financial adviser authorised under the Financial Services and Markets Act 2000 or, if you are located outside the United Kingdom, from an appropriately authorised independent financial adviser.

Forward-looking statements

The materials on this part of the website, including information included or incorporated by reference, may contain certain forward-looking statements with respect to the financial condition, results of operations and business of the Company. These statements are based on the current expectation of the management of the Company and are naturally subject to uncertainty and changes in circumstances. These forward-looking statements may be identified by words such as “expectation”, “belief”, “estimate”, “plan”, “target”, or “forecast” and similar expressions or the negative thereof; or by forward-looking nature of discussions of strategy, plans or intentions; or by their context.

By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. There are several factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are changes in the global, political, economic, business, competitive, market and regulatory forces, future exchange and interest rates, changes in tax rates and future business combinations or dispositions. Due to such uncertainties, the Company cannot give any assurance that any forward-looking statement will prove to be correct in the future. The Company does not undertake any obligation to update or publicly revise forward-looking statements (whether as a result of new information, future events or otherwise), except to the extent required by applicable law or regulation. You are therefore cautioned not to place undue reliance on these forward-looking statements.

Confirmation of understanding and acceptance of disclaimer

By clicking on the “I Agree” button, I confirm that I am not located or resident in a jurisdiction where accessing these materials is unlawful, and that I intend to access this part of the website for information purposes only, and I agree that I will not print, download, or otherwise seek to copy, mail, forward, distribute or send any of the materials on this area of the website to any other person at any time.

I have read and understood the disclaimer set out above. I understand that it may affect my rights or responsibilities and I agree to be bound by its terms. By clicking on the “I Agree” button, I confirm that I am permitted to proceed to electronic versions of these materials.

I understand that it may affect my rights. I agree to be bound by its terms.
Disclaimer - Important - NetScientific
No announcement available or all announcement expired.